{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:25:32Z","timestamp":1766395532662,"version":"3.48.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1188959"],"award-info":[{"award-number":["GNT1188959"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1072113"],"award-info":[{"award-number":["APP1072113"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bcp.2025.117565","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T07:42:13Z","timestamp":1764315733000},"page":"117565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Singapore blue arboreal tarantula peptide Lv1a preferentially targets NaV1.6 with new world\u2013like pharmacological mechanism"],"prefix":"10.1016","volume":"244","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0068-9974","authenticated-orcid":false,"given":"Fernanda C.","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A.I.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bcp.2025.117565_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11090488","article-title":"Phylogeny-guided selection of priority groups for venom bioprospecting: harvesting toxin sequences in tarantulas as a case study","volume":"11","author":"Luddecke","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.bcp.2025.117565_b0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fphar.2019.00366","article-title":"Structure-function and therapeutic potential of spider venom-derived cysteine knot peptides targeting sodium channels","volume":"10","author":"Cardoso","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117565_b0015","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/bph.13962","article-title":"Sodium channels and pain: from toxins to therapies","volume":"175","author":"Cardoso","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117565_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114107","article-title":"Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases","volume":"181","author":"Cardoso","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117565_b0025","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-020-16210-y","article-title":"Spider venom-derived peptide induces hyperalgesia in NaV1.7 knockout mice by activating NaV1.9 channels","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2025.117565_b0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/j.pain.0000000000002041","article-title":"A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome","volume":"162","author":"Cardoso","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2025.117565_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1069764","article-title":"Holistic profiling of the venom from the Brazilian wandering spider Phoneutria nigriventer by combining high-throughput ion channel screens with venomics","volume":"10","author":"Cardoso","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bcp.2025.117565_b0040","article-title":"High-content fluorescence bioassay investigates pore formation, ion channel modulation and cell membrane lysis induced by venoms","volume":"21","author":"Kramer","year":"2024","journal-title":"Toxicon: X"},{"key":"10.1016\/j.bcp.2025.117565_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.742457","article-title":"Engineering of a spider peptide via conserved structure-function traits optimizes sodium channel inhibition in vitro and anti-nociception in vivo","volume":"8","author":"Hu","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bcp.2025.117565_b0050","doi-asserted-by":"crossref","unstructured":"G. Wisedchaisri, L. Tonggu, T.M. Gamal El-Din, E. McCord, N. Zheng, W.A. Catterall, Structural basis for high-affinity trapping of the NaV1.7 channel in its resting state by tarantula toxin, Mol Cell 81(1) (2021) 38-48 e4.","DOI":"10.1016\/j.molcel.2020.10.039"},{"issue":"2","key":"10.1016\/j.bcp.2025.117565_b0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.toxicon.2008.11.002","article-title":"Intersexual variations in the pharmacological properties of Coremiocnemis tropix (Araneae, Theraphosidae) spider venom","volume":"53","author":"Herzig","year":"2009","journal-title":"Toxicon"},{"issue":"11","key":"10.1016\/j.bcp.2025.117565_b0060","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.bcp.2012.02.022","article-title":"Characterisation of Na(v) types endogenously expressed in human SH-SY5Y neuroblastoma cells","volume":"83","author":"Vetter","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117565_b0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/mol.115.098178","article-title":"Identification and characterization of ProTx-III [\u03bc-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma Pruriens","volume":"88","author":"Cardoso","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117565_b0070","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","article-title":"The HADDOCK2.2 Web Server: user-friendly integrative modeling of biomolecular complexes","volume":"428","author":"van Zundert","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117565_b0075","article-title":"The PyMOL Molecular Graphics System, Version 2.4.1 Schr\u00f6dinger","author":"DeLano","year":"2002","journal-title":"LLC"},{"issue":"7873","key":"10.1016\/j.bcp.2025.117565_b0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117565_b0085","doi-asserted-by":"crossref","unstructured":"H. Xu, T. Li, A. Rohou, C.P. Arthur, F. Tzakoniati, E. Wong, A. Estevez, C. Kugel, Y. Franke, J. Chen, C. Ciferri, D.H. Hackos, C.M. Koth, J. Payandeh, Structural basis of NaV1.7 inhibition by a gating-modifier spider toxin, Cell 176(4) (2019) 702-715 e14.","DOI":"10.1016\/j.cell.2018.12.018"},{"key":"10.1016\/j.bcp.2025.117565_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1277143","article-title":"Structure-function and rational design of a spider toxin Ssp1a at human voltage-gated sodium channel subtypes","volume":"14","author":"Dongol","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117565_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11110626","article-title":"Spider knottin pharmacology at voltage-gated sodium channels and their potential to modulate pain pathways","volume":"11","author":"Dongol","year":"2019","journal-title":"Toxins (basel)"},{"key":"10.1016\/j.bcp.2025.117565_b0100","doi-asserted-by":"crossref","unstructured":"T.J. Dolinsky, J.E. Nielsen, J.A. McCammon, N.A. Baker, PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations, Nucleic Acids Res 32(Web Server issue) (2004) W665-7.","DOI":"10.1093\/nar\/gkh381"},{"issue":"15","key":"10.1016\/j.bcp.2025.117565_b0105","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1111\/bph.13865","article-title":"Modulatory features of the novel spider toxin \u03bc-TRTX-Df1a isolated from the venom of the spider Davus fasciatus","volume":"174","author":"Cardoso","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117565_b0110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2018.02.016","article-title":"Direct evidence for high affinity blockade of Na(V)1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches","volume":"133","author":"Goncalves","year":"2018","journal-title":"Neuropharmacology"},{"issue":"6433","key":"10.1016\/j.bcp.2025.117565_b0115","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.aaw2493","article-title":"Structures of human NaV1.7 channel in complex with auxiliary subunits and animal toxins","volume":"363","author":"Shen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117565_b0120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83761","article-title":"The deep-rooted origin of disulfide-rich spider venom toxins","volume":"12","author":"Shaikh","year":"2023","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.bcp.2025.117565_b0125","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae275","article-title":"Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides","volume":"25","author":"Goles","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"5","key":"10.1016\/j.bcp.2025.117565_b0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tips.2025.03.007","article-title":"Venom peptides regulating Ca2+ homeostasis: neuroprotective potential","volume":"46","author":"Muller","year":"2025","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:23:12Z","timestamp":1766395392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225008305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":26,"alternative-id":["S0006295225008305"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117565","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Singapore blue arboreal tarantula peptide Lv1a preferentially targets NaV1.6 with new world\u2013like pharmacological mechanism","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117565"}}